Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Heitz

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Biochimie|January 1, 1994
The human testis determining factor SRY: a new member of the HMG box protein familyS Soullier, F Poulat, B Boizet-Bonhoure, et al.
The Journal of Membrane Biology|May 16, 1998
Interactions of primary amphipathic vector peptides with membranes. Conformational consequences and influence on cellular localizationP Vidal, L Chaloin, A Heitz, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 10, 1998
Capping and dynamic relation between domains 1 and 2 of gelsolinJ Feinberg, O Kwiatek, C Astier, et al.
Biophysical Journal|May 12, 2009
Structural information from functional measurements: single-channel studies on gramicidin analoguesJ T Durkin, O S Andersen, E R Blout, et al.
Peptide Research|March 1, 1992
Endothelin 1: conformation and aggregationB Calas, M C Harricane, L Guimard, et al.
Biochemistry|June 16, 1992
Gramicidin channels that have no tryptophan residuesV Fonseca, P Daumas, L Ranjalahy-Rasoloarijao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metaboliteV Fischer, A Rodríguez-Gascón, F Heitz, et al.
Biology of the Neonate|January 1, 1988
Left ventricular diastolic function during the first month of lifeJ C Fouron, F Heitz, A M Carceller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactionsV Fischer, L Johanson, F Heitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetronV Fischer, A E Vickers, F Heitz, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Biochimie|January 1, 1994
The human testis determining factor SRY: a new member of the HMG box protein familyS Soullier, F Poulat, B Boizet-Bonhoure, et al.
The Journal of Membrane Biology|May 16, 1998
Interactions of primary amphipathic vector peptides with membranes. Conformational consequences and influence on cellular localizationP Vidal, L Chaloin, A Heitz, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 10, 1998
Capping and dynamic relation between domains 1 and 2 of gelsolinJ Feinberg, O Kwiatek, C Astier, et al.
Biophysical Journal|May 12, 2009
Structural information from functional measurements: single-channel studies on gramicidin analoguesJ T Durkin, O S Andersen, E R Blout, et al.
Peptide Research|March 1, 1992
Endothelin 1: conformation and aggregationB Calas, M C Harricane, L Guimard, et al.
Biochemistry|June 16, 1992
Gramicidin channels that have no tryptophan residuesV Fonseca, P Daumas, L Ranjalahy-Rasoloarijao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 11, 1998
The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metaboliteV Fischer, A Rodríguez-Gascón, F Heitz, et al.
Biology of the Neonate|January 1, 1988
Left ventricular diastolic function during the first month of lifeJ C Fouron, F Heitz, A M Carceller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin: effect on human cytochrome P-450 and implications for metabolic drug interactionsV Fischer, L Johanson, F Heitz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1994
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetronV Fischer, A E Vickers, F Heitz, et al.
Pageof 18